282 related articles for article (PubMed ID: 32228106)
1. Synthetic lethality on drug discovery: an update on cancer therapy.
Yar MS; Haider K; Gohel V; Siddiqui NA; Kamal A
Expert Opin Drug Discov; 2020 Jul; 15(7):823-832. PubMed ID: 32228106
[TBL] [Abstract][Full Text] [Related]
2. Embracing synthetic lethality of novel anticancer therapies.
Kamal A; Shaik TB; Malik MS
Expert Opin Drug Discov; 2015 Oct; 10(10):1119-32. PubMed ID: 26211783
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Lethality Targeting Polθ.
Drzewiecka M; Barszczewska-Pietraszek G; Czarny P; Skorski T; Śliwiński T
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741863
[TBL] [Abstract][Full Text] [Related]
4. Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.
Topatana W; Juengpanich S; Li S; Cao J; Hu J; Lee J; Suliyanto K; Ma D; Zhang B; Chen M; Cai X
J Hematol Oncol; 2020 Sep; 13(1):118. PubMed ID: 32883316
[TBL] [Abstract][Full Text] [Related]
5. DNA Double Strand Break Repair - Related Synthetic Lethality.
Toma M; Skorski T; Sliwinski T
Curr Med Chem; 2019; 26(8):1446-1482. PubMed ID: 29421999
[TBL] [Abstract][Full Text] [Related]
6. Link synthetic lethality to drug sensitivity of cancer cells.
Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
[TBL] [Abstract][Full Text] [Related]
7. Synthetic lethality as an engine for cancer drug target discovery.
Huang A; Garraway LA; Ashworth A; Weber B
Nat Rev Drug Discov; 2020 Jan; 19(1):23-38. PubMed ID: 31712683
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
Gupta A; Ahmad A; Dar AI; Khan R
Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
[TBL] [Abstract][Full Text] [Related]
9. A systematic analysis of the landscape of synthetic lethality-driven precision oncology.
Schäffer AA; Chung Y; Kammula AV; Ruppin E; Lee JS
Med; 2024 Jan; 5(1):73-89.e9. PubMed ID: 38218178
[TBL] [Abstract][Full Text] [Related]
10. Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network.
Liu L; Chen X; Hu C; Zhang D; Shao Z; Jin Q; Yang J; Xie H; Liu B; Hu M; Ke K
Sci Rep; 2018 May; 8(1):8440. PubMed ID: 29855504
[TBL] [Abstract][Full Text] [Related]
11. SL
Liu Y; Wu M; Liu C; Li XL; Zheng J
IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(3):748-757. PubMed ID: 30969932
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Lethality - Its Current Application and Potential in Oncological Treatment.
Bortlíková L; Müller P; Vojtěšek B; Rak V; Svoboda M
Klin Onkol; 2019; 32(Supplementum 3):19-24. PubMed ID: 31627702
[TBL] [Abstract][Full Text] [Related]
13. The development of PARP as a successful target for cancer therapy.
Ferrara R; Simionato F; Ciccarese C; Grego E; Cingarlini S; Iacovelli R; Bria E; Tortora G; Melisi D
Expert Rev Anticancer Ther; 2018 Feb; 18(2):161-175. PubMed ID: 29260919
[TBL] [Abstract][Full Text] [Related]
14. Synthetic Lethality in Cancer Therapeutics: The Next Generation.
Setton J; Zinda M; Riaz N; Durocher D; Zimmermann M; Koehler M; Reis-Filho JS; Powell SN
Cancer Discov; 2021 Jul; 11(7):1626-1635. PubMed ID: 33795234
[TBL] [Abstract][Full Text] [Related]
15. Synthetic lethality: emerging targets and opportunities in melanoma.
Thompson N; Adams DJ; Ranzani M
Pigment Cell Melanoma Res; 2017 Mar; 30(2):183-193. PubMed ID: 28097822
[TBL] [Abstract][Full Text] [Related]
16. Syn-lethality: an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies.
Li XJ; Mishra SK; Wu M; Zhang F; Zheng J
Biomed Res Int; 2014; 2014():196034. PubMed ID: 24864230
[TBL] [Abstract][Full Text] [Related]
17. PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside.
Turk AA; Wisinski KB
Cancer; 2018 Jun; 124(12):2498-2506. PubMed ID: 29660759
[TBL] [Abstract][Full Text] [Related]
18. Synthetic lethality screens point the way to new cancer drug targets.
Mullard A
Nat Rev Drug Discov; 2017 Sep; 16(9):589-591. PubMed ID: 28860588
[No Abstract] [Full Text] [Related]
19. The role of drug-metabolizing enzymes in synthetic lethality of cancer.
Zeng Z; Zheng W; Hou P
Pharmacol Ther; 2022 Dec; 240():108219. PubMed ID: 35636517
[TBL] [Abstract][Full Text] [Related]
20. Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics.
Bhattacharjee S; Nandi S
IUBMB Life; 2017 Dec; 69(12):929-937. PubMed ID: 29171189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
